Corneal Collagen Cross-linking for Progressive Keratoconus
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
Prospective, randomized multicenter study to determine the safety and effectiveness of
performing cornea collagen cross-linking (CXL) using riboflavin and UVA light in eyes with
progressive keratoconus.